5 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder (ASD) in Pediatric PatientsIrritability Associated With Autism Spectrum DisorderRecruitingPhase 32026-09-25NCT06706674
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric PatientsBipolar and Related Disorders, bipolar disorder, mood disorder, psychiatric disorderRecruitingPhase 32026-09-25NCT06372964
Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum DisorderBipolar and Related Disorders, Schizophrenia Spectrum and Other Psychotic Disorders, autism spectrum disorder, bipolar disorder, mood disorder, neurodevelopmental disorder, pervasive developmental disorder, psychiatric disorder, schizophreniaRecruitingPhase 32026-09-25NCT06229210
Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Bipolar I DisorderMania, Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, bipolar I disorder, nervous system disorderActive, not recruitingPhase 22026-08-10NCT07046494
Safety and Efficacy Study of VNX001 Compared to Its Individual Components (Lidocaine and Heparin) or Placebo in Subjects With IC/BPSFemale Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Urogenital Diseases, cystitis, interstitial cystitis, urinary bladder disorder, urinary system disorderRecruitingPhase 22026-01-22NCT05737121